Alto Neuroscience, Inc.
ANRO
$2.05
-$0.02-0.97%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/9/2025
-
MarketBeat
4/8/2025
-
Yahoo! Finance: News
4/7/2025
-
The Fly
3/24/2025
-
TipRanks Financial Blog
3/24/2025
-
MarketBeat
3/24/2025
-
MarketBeat
3/22/2025
-
MarketBeat
3/22/2025
-
MarketBeat
3/21/2025
-
MarketBeat
3/21/2025
-
Ticker Report
3/21/2025
-
TipRanks Financial Blog
3/20/2025
-
TipRanks Financial Blog
3/20/2025
-
GuruFocus
3/20/2025
-
Business Wire
3/13/2025
-
GuruFocus
3/13/2025
-
PR Newswire
3/13/2025
-
MarketBeat
3/10/2025
-
ETF Channel
3/3/2025
-
The Fly
3/3/2025
-
The Fly
3/3/2025
-
Stocktwits News Feed
2/25/2025
-
GuruFocus
2/25/2025
-
Business Wire
2/19/2025
-
GuruFocus
2/19/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 20, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 200 0412
Address
650 Castro Street
Mountain View, CA 94041
Mountain View, CA 94041
Country
Year Founded
Business Description
Sector
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s product pipeline comprising ALTO-100, which is in phase 2b clinical trial for...
more
